243 related articles for article (PubMed ID: 16452487)
41. Unraveling a hotspot for TCR recognition on HLA-A2: evidence against the existence of peptide-independent TCR binding determinants.
Gagnon SJ; Borbulevych OY; Davis-Harrison RL; Baxter TK; Clemens JR; Armstrong KM; Turner RV; Damirjian M; Biddison WE; Baker BM
J Mol Biol; 2005 Oct; 353(3):556-73. PubMed ID: 16197958
[TBL] [Abstract][Full Text] [Related]
42. Signal peptide peptidase is required for dislocation from the endoplasmic reticulum.
Loureiro J; Lilley BN; Spooner E; Noriega V; Tortorella D; Ploegh HL
Nature; 2006 Jun; 441(7095):894-7. PubMed ID: 16738546
[TBL] [Abstract][Full Text] [Related]
43. Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11.
Schust DJ; Tortorella D; Seebach J; Phan C; Ploegh HL
J Exp Med; 1998 Aug; 188(3):497-503. PubMed ID: 9687527
[TBL] [Abstract][Full Text] [Related]
44. Binding of BCR/ABL junctional peptides to major histocompatibility complex (MHC) class I molecules: studies in antigen-processing defective cell lines.
Cullis JO; Barrett AJ; Goldman JM; Lechler RI
Leukemia; 1994 Jan; 8(1):165-70. PubMed ID: 8289483
[TBL] [Abstract][Full Text] [Related]
45. A conserved energetic footprint underpins recognition of human leukocyte antigen-E by two distinct αβ T cell receptors.
Sullivan LC; Walpole NG; Farenc C; Pietra G; Sum MJW; Clements CS; Lee EJ; Beddoe T; Falco M; Mingari MC; Moretta L; Gras S; Rossjohn J; Brooks AG
J Biol Chem; 2017 Dec; 292(51):21149-21158. PubMed ID: 28972140
[TBL] [Abstract][Full Text] [Related]
46. Molecular dynamics study of a complex between the human histocompatibility antigen HLA-A2 and the IMP58-66 nonapeptide from influenza virus matrix protein.
Rognan D; Zimmermann N; Jung G; Folkers G
Eur J Biochem; 1992 Aug; 208(1):101-13. PubMed ID: 1511679
[TBL] [Abstract][Full Text] [Related]
47. Automatic sequence design of major histocompatibility complex class I binding peptides impairing CD8+ T cell recognition.
Ogata K; Jaramillo A; Cohen W; Briand JP; Connan F; Choppin J; Muller S; Wodak SJ
J Biol Chem; 2003 Jan; 278(2):1281-90. PubMed ID: 12411444
[TBL] [Abstract][Full Text] [Related]
48. CH/pi interactions in the crystal structure of class I MHC antigens and their complexes with peptides.
Umezawa Y; Nishio M
Bioorg Med Chem; 1998 Dec; 6(12):2507-15. PubMed ID: 9925306
[TBL] [Abstract][Full Text] [Related]
49. Plasticity in the contribution of T cell receptor variable region residues to binding of peptide-HLA-A2 complexes.
Smith SN; Sommermeyer D; Piepenbrink KH; Blevins SJ; Bernhard H; Uckert W; Baker BM; Kranz DM
J Mol Biol; 2013 Nov; 425(22):4496-507. PubMed ID: 23954306
[TBL] [Abstract][Full Text] [Related]
50. Molecular analysis of presentation by HLA-A2.1 of a promiscuously binding V3 loop peptide from the HIV-envelope protein to human cytotoxic T lymphocytes.
Alexander-Miller MA; Parker KC; Tsukui T; Pendleton CD; Coligan JE; Berzofsky JA
Int Immunol; 1996 May; 8(5):641-9. PubMed ID: 8671651
[TBL] [Abstract][Full Text] [Related]
51. Poor binding of a HER-2/neu epitope (GP2) to HLA-A2.1 is due to a lack of interactions with the center of the peptide.
Kuhns JJ; Batalia MA; Yan S; Collins EJ
J Biol Chem; 1999 Dec; 274(51):36422-7. PubMed ID: 10593938
[TBL] [Abstract][Full Text] [Related]
52. Structural insights into the binding of hepatitis B virus core peptide to HLA-A2 alleles: towards designing better vaccines.
Liu J; Chen KY; Ren EC
Eur J Immunol; 2011 Jul; 41(7):2097-106. PubMed ID: 21538979
[TBL] [Abstract][Full Text] [Related]
53. Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: impact on target susceptibility to NK cell subsets.
Llano M; Gumá M; Ortega M; Angulo A; López-Botet M
Eur J Immunol; 2003 Oct; 33(10):2744-54. PubMed ID: 14515258
[TBL] [Abstract][Full Text] [Related]
54. Molecular comparisons of the beta 2-microglobulin-binding site in class I major-histocompatibility-complex alpha-chains and proteins of related sequences.
Tysoe-Calnon VA; Grundy JE; Perkins SJ
Biochem J; 1991 Jul; 277 ( Pt 2)(Pt 2):359-69. PubMed ID: 1859364
[TBL] [Abstract][Full Text] [Related]
55. TRAM1 participates in human cytomegalovirus US2- and US11-mediated dislocation of an endoplasmic reticulum membrane glycoprotein.
Oresic K; Ng CL; Tortorella D
J Biol Chem; 2009 Feb; 284(9):5905-14. PubMed ID: 19121997
[TBL] [Abstract][Full Text] [Related]
56. Disruption of hydrogen bonds between major histocompatibility complex class II and the peptide N-terminus is not sufficient to form a human leukocyte antigen-DM receptive state of major histocompatibility complex class II.
Schulze MS; Anders AK; Sethi DK; Call MJ
PLoS One; 2013; 8(7):e69228. PubMed ID: 23976922
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.
Hegde NR; Tomazin RA; Wisner TW; Dunn C; Boname JM; Lewinsohn DM; Johnson DC
J Virol; 2002 Nov; 76(21):10929-41. PubMed ID: 12368336
[TBL] [Abstract][Full Text] [Related]
58. T cell activity correlates with oligomeric peptide-major histocompatibility complex binding on T cell surface.
Buslepp J; Zhao R; Donnini D; Loftus D; Saad M; Appella E; Collins EJ
J Biol Chem; 2001 Dec; 276(50):47320-8. PubMed ID: 11584024
[TBL] [Abstract][Full Text] [Related]
59. Visualization of the ER-to-cytosol dislocation reaction of a type I membrane protein.
Fiebiger E; Story C; Ploegh HL; Tortorella D
EMBO J; 2002 Mar; 21(5):1041-53. PubMed ID: 11867532
[TBL] [Abstract][Full Text] [Related]
60. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
Maeurer MJ; Chan HW; Karbach J; Salter RD; Knuth A; Lotze MT; Storkus WJ
Eur J Immunol; 1996 Nov; 26(11):2613-23. PubMed ID: 8921947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
